| Characteristic | Brands | Unbranded Generics | Branded Generics |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
April 2022
Region
United States
Survey time period
2006 to 2021
Supplementary notes
Statistic includes non-discounted spending. All figures are rounded and were calculated based on IQVIA data. Includes prescriptions and insulins dispensed by chain and independent pharmacies, food store pharmacies, mail service pharmacies, and long-term
care facilities. Spending figures also include sales into hospitals, clinics, and other institutional settings.
Values before 2012 were taken from the GPhA 2010 Annual Report and were not restated.
* Restated.
Citation formats









